Back to Search
AMY HEIMBERGER, M.D.
M.D.
Neurological Surgery Physician
NPI: 1235220955IndividualAccepts Medicare
Specialties, Licenses & Credentials
Surgical Oncology Physician
Surgery — Surgical Oncology
Code: 2086X0206X
L6422(TX)
Neurological Surgery PhysicianPrimary
Neurological Surgery
Code: 207T00000X
036155266(IL)
CMS Specialties
PrimaryNEUROSURGERY
Education
WASHINGTON UNIVERSITY SCHOOL OF MEDICINE
Class of 1995
Research & Publications (20)
IgE, allergy, and risk of glioma: update from the San Francisco Bay Area Adult Glioma Study in the temozolomide era.
PMID 19408307·Int J Cancer·2009
8-other
Awake craniotomy for brain tumors near eloquent cortex: correlation of intraoperative cortical mapping with neurological outcomes in 309 consecutive patients.
PMID 19404147·Neurosurgery·2009
3-trial
The PEPvIII-KLH (CDX-110) vaccine in glioblastoma multiforme patients.
PMID 19591631·Expert Opin Biol Ther·2009
6-review
A novel phosphorylated STAT3 inhibitor enhances T cell cytotoxicity against melanoma through inhibition of regulatory T cells.
PMID 19002459·Cancer Immunol Immunother·2009
8-other
Modulation of angiogenic and inflammatory response in glioblastoma by hypoxia.
PMID 19536297·PLoS One·2009
8-other
Small molecular inhibitors of p-STAT3: novel agents for treatment of primary and metastatic CNS cancers.
PMID 18991807·Recent Pat CNS Drug Discov·2008
6-review
A novel inhibitor of signal transducers and activators of transcription 3 activation is efficacious against established central nervous system melanoma and inhibits regulatory T cells.
PMID 18794085·Clin Cancer Res·2008
7-preclinical
Detection of humoral response in patients with glioblastoma receiving EGFRvIII-KLH vaccines.
PMID 18775433·J Immunol Methods·2008
3-trial
Incidence and prognostic impact of FoxP3+ regulatory T cells in human gliomas.
PMID 18698034·Clin Cancer Res·2008
8-other
Immunological responses in a patient with glioblastoma multiforme treated with sequential courses of temozolomide and immunotherapy: case study.
PMID 18079360·Neuro Oncol·2008
5-case
Tumor-specific immunotherapy targeting the EGFRvIII mutation in patients with malignant glioma.
PMID 18539480·Semin Immunol·2008
6-review
Preferential migration of regulatory T cells mediated by glioma-secreted chemokines can be blocked with chemotherapy.
PMID 17522861·Cancer Immunol Immunother·2008
8-other
The incidence, correlation with tumor-infiltrating inflammation, and prognosis of phosphorylated STAT3 expression in human gliomas.
PMID 19088040·Clin Cancer Res·2008
8-other
Epidermal growth factor receptor variant III status defines clinically distinct subtypes of glioblastoma.
PMID 17538175·J Clin Oncol·2007
8-other
A novel small molecule inhibitor of signal transducers and activators of transcription 3 reverses immune tolerance in malignant glioma patients.
PMID 17942891·Cancer Res·2007
7-preclinical
Altered adenosine-to-inosine RNA editing in human cancer.
PMID 17908822·Genome Res·2007
4-observational
Cytochrome P450 1B1 expression in glial cell tumors: an immunotherapeutic target.
PMID 17575219·Clin Cancer Res·2007
8-other
Prognostic associations of activated mitogen-activated protein kinase and Akt pathways in glioblastoma.
PMID 16818690·Clin Cancer Res·2006
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
Via practice · 2 locations total
- Address
- 675 N SAINT CLAIR ST STE 20-100
CHICAGO, IL 60611 - Phone
- (312) 695-8143
Quick Facts
- NPI
- 1235220955
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Accepted
- Specialties
- 2
- Locations
- 2
- Years in Practice
- 31
- Publications
- 20
Are you this provider?
Claim Your Profile